Drug design and screening for anti malarials
Session Chair: Barry Hardy, Douglas Connect / Scientists Against Malaria
Monday, 9 February 2015
from 09:00 to 12:00
|Jurgen Bosch, Johns Hopkins
|Protein-protein Interaction Inhibitors in Antimalarial Drug Design
|Barry Hardy, Scientists Against Malaria
|Malarial Kinase Inhibitor Design and Screening
|Paul Hawkins, OpenEye Scientific Software
|Ligand-based virtual screening in 3D: where is the signal?
|Raymond Hui, Structural Genomics Consortium
|Structural Biology of Malarial Kinases
This session will discuss the application of computational chemistry, drug design, virtual and experimental screening techniques to the design of inhibitors against malarial targets.
|SESSION 2 >>